A detailed history of Qube Research & Technologies LTD transactions in Angiodynamics Inc stock. As of the latest transaction made, Qube Research & Technologies LTD holds 11,442 shares of ANGO stock, worth $88,103. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,442
Previous 143,999 92.05%
Holding current value
$88,103
Previous $845,000 91.83%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$5.65 - $7.03 $748,947 - $931,875
-132,557 Reduced 92.05%
11,442 $69,000
Q1 2024

May 14, 2024

BUY
$5.27 - $8.03 $337,706 - $514,570
64,081 Added 80.18%
143,999 $845,000
Q4 2023

Feb 13, 2024

SELL
$6.17 - $8.04 $285,294 - $371,761
-46,239 Reduced 36.65%
79,918 $626,000
Q3 2023

Nov 13, 2023

BUY
$7.02 - $10.32 $328,746 - $483,285
46,830 Added 59.03%
126,157 $922,000
Q2 2023

Aug 14, 2023

SELL
$8.29 - $11.16 $192,336 - $258,923
-23,201 Reduced 22.63%
79,327 $827,000
Q1 2023

May 15, 2023

BUY
$9.1 - $15.48 $98,971 - $168,360
10,876 Added 11.87%
102,528 $1.06 Million
Q4 2022

Feb 14, 2023

BUY
$12.06 - $21.55 $1.11 Million - $1.98 Million
91,652 New
91,652 $1.26 Million
Q2 2022

Aug 15, 2022

SELL
$17.83 - $24.49 $503,715 - $691,866
-28,251 Closed
0 $0
Q1 2022

May 09, 2022

BUY
$20.46 - $29.16 $169,306 - $241,299
8,275 Added 41.42%
28,251 $609,000
Q4 2021

Feb 01, 2022

SELL
$24.35 - $30.97 $230,107 - $292,666
-9,450 Reduced 32.11%
19,976 $551,000
Q3 2021

Nov 12, 2021

BUY
$23.36 - $29.2 $478,296 - $597,870
20,475 Added 228.75%
29,426 $763,000
Q2 2021

Aug 13, 2021

BUY
$22.39 - $28.07 $200,412 - $251,254
8,951 New
8,951 $243,000
Q1 2020

May 15, 2020

SELL
$8.33 - $16.9 $133,871 - $271,599
-16,071 Closed
0 $0
Q4 2019

Feb 13, 2020

BUY
$14.23 - $18.16 $228,690 - $291,849
16,071 New
16,071 $257,000

Others Institutions Holding ANGO

About ANGIODYNAMICS INC


  • Ticker ANGO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 39,107,800
  • Market Cap $301M
  • Description
  • AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and vascular access; and for use in oncology and surgical settings in the United States and internationally. The company provides NanoKnife ablation syst...
More about ANGO
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.